OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Addiction Medicine is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
A Naturalistic Study of Individuals Involved in the Justice System Who Experienced Both Formulations of Extended-release Buprenorphine	70
Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations	67
Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al.	60
The Pharmacological Management of Ketamine Use Disorder: A Systematic Review	59
Characteristics of Ongoing Clinical Trials for Cocaine Use Disorder Registered on Global Clinical Trial Databases	49
Perinatal Substance Use-Related Content at Major Addiction Scientific Conferences: An Analysis of Oral Presentation Sessions	44
Generative Artificial Intelligence Tools in Medicine Will Amplify Stigmatizing Language	44
Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations	40
GLP-1 RA Medication Associations With Hazardous Alcohol Drinking Reductions in Patients With Overweight or Obesity: A Prospective Observational Study	37
Synthetic Cathinone–Induced Myocarditis and Psychosis: A Case Report	36
Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals	35
Initiating Long-acting Injectable Naltrexone: Procedure for a Second Attempt After a First Attempt Fails	34
Managing Benzodiazepine Withdrawal—The Emperor’s New Clothes	34
A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-associated Liver Disease	33
Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women’s Prison Facility, 2016–2019	31
A Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era	28
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial	25
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder	25
Implantable Cardioverter Defibrillator Placement to Permit Ongoing Methadone Treatment Despite QT Prolongation and Torsades de Pointes: A Case Report	23
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study	22
Trauma Prevalence and Its Association With Health-related Quality of Life in Pregnant Persons With Opioid Use Disorder	22
Assessing Childhood Maltreatment Exposure in Patients Without and With a Diagnosis of Substance Use Disorder	22
Individuals Dispensed Buprenorphine in the United States Before and After Federal Policy Changes Aimed at Increasing Access	21
Fentanyl Test Strips for Harm Reduction: A Scoping Review	20
A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial	20

Use of Cannabinoids by People Who Consume Kratom in the United States	19
Complicating Factors Surrounding Concurrent Use of Kratom and a Novel 7-hydroxymitragynine Product Among a Participant Enrolled in a Kratom Clinical Trial	17
Adolescent Tobacco/Nicotine Use and the Potential Role of Contingency Management-based Interventions	17
High Primary COVID-19 Vaccine Series Completion by People Who Inject Drugs When Colocating Services at a Syringe Services Van	17
Approaches for Managing Benzodiazepine Dependence Arising From Use of the Adulterated Opioid Supply: A Delphi Technique	16
Clinical and Demographic Characteristics of Hospitalized Patients With Xylazine-related Wounds	16
Identifying Areas to Improve Care and Support Parent-Child Relationships From the Perspective of Pregnant and Parenting People in Recovery	16
Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States	15
Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review	15
Feasibility of Emergency Department–based Fentanyl Test Strip Distribution	14
Subcutaneous Extended-release Buprenorphine Depot Misdiagnosed as an Abscess Resulting in Incision and Drainage and Disruption of Opioid Use Disorder Treatment	14
Outcomes in Subsequent Pregnancies of Individuals With Opioid Use Disorder Treated in Multidisciplinary Clinic in Prior Pregnancy	14
Adapting Contingency Management for Hospitalized Patients with Stimulant Use Disorder	14
Stigmatizing Language in Substance Use-related International Classification of Diseases Codes	14
Testing and Case Rates of Gonorrhea, Chlamydia, Syphilis, and HIV among People with Substance Use Disorders in the Veterans Health Administration	13
Associations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards Surveys	13
Dosing and Safety of Methadone Initiation in the Setting of Fentanyl: A Systematic Review	13
Provider Perceptions Toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder	13
Xylazine Use Among People Who Inject Drugs, Philadelphia 2022	13
Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19	13
Systematic Review of Obstetric and Child Outcomes of Prenatal Exposure to Inhalants in the Context of a Use Disorder	12
Public Xylazine Awareness and Support for Policies and Initiatives to Address the Xylazine Threat Among US Adults	12
The Association Between Perceived Injustice and Opioid Craving in Patients With Chronic Pain: The Mediating Role of Daily Pain Intensity, Negative Affect, and Catastrophizing	12
Medical Detoxification for Nonopioid Substances Is Associated With Lower Likelihood of Subsequent Linkage to Substance Use Disorder Treatment	12
Climate Change and the Opioid Epidemic	12
Exploring Family Planning Perspectives Among Men Receiving Medications for Opioid Use Disorder: Implications for Service Development	11
A Hospital-based Managed Alcohol Program in a Canadian Setting	11
The Effect of Dehydroepiandrosterone Administration during Rehabilitation on White Matter Integrity Among Individuals With Polysubstance Use Disorder	11
Online Narcotics Anonymous: An Option for Addressing Methamphetamine Use Disorder	11
Current State of Perioperative Buprenorphine Management—A National Provider Survey	10
Opioid Settlements: The Role for Addiction Medicine in Guiding Effective Spending	10
Estimating the Prevalence of Using Suspected Counterfeit Medications in the General Population	10
Integrative Analysis of Proteome-wide Association Studies and Functional Enrichment Analysis to Identify Genes and Chemicals Associated with Alcohol Dependence	10
Clinical Presentations and Treatment of Phenibut Toxicity and Withdrawal: A Systematic Literature Review	10
Response to: “Prevalence of Kratom Use Disorder among Kratom Consumers”	10
Insurance-related Risk Factors for Leaving Against Medical Advice after Opioid Overdose: A Cross-sectional Study Using Electronic Health Records	10
Letter in Reply	10
The Difficulties in Finding the Relevant Associations Between Internet Gaming Disorder (IGD) and the Incidence of Suicide-Related Ideation and Behaviors in College Students	9
Retention With Medication for Opioid Use Disorder: The Role of the Primary Care Relationship	9
Discordance Between Self-reported and Biologically Tested Exposure to Fentanyl Among People at Risk of Opioid Overdose	9
Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder	9
Xylazine Test Strip Use Among People Who Use Drugs in New York State	9
ASAM/AAAP Clinical Practice Guideline (CPG) for Stimulant Use Disorder (StUD) Management: Commentary on Research Priorities	9
Investigating Healthcare Provider Bias Toward Patients Who Use Drugs Using a Survey-based Implicit Association Test: Pilot Study	9
Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens	9
Retention and Overdose Risk among Patients Receiving Substance Use Disorder Treatment, Mental Health Care and Peer Recovery Support: A Longitudinal Analysis	9
The Use of Pattern Recognition to Augment Traditional Monitoring in the Prevention of Opioid Overdose Harm	9
Evidence of “Repeated Admission Bias” Among Those Who Use Injection Drugs Across 2 Decades of US Treatment Admissions: 2000–2020	9
48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method	9
Increasing Initiation of Medications for Opioid Use Disorder Through Recovery Coaches: The Role of Implementation Setting	9

Integration of Substance Use Disorder Services in Veterans Affairs Primary Care Clinics Serving Homeless Women	9
Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine	8
The Shifting Landscape of a Fentanyl Adulterant: Moving From Xylazine to Medetomidine	8
Perceptions of Overdose Response Hotlines and Phone Application Services Among Women and Gender-diverse Individuals Who Use Drugs in Canada: A Qualitative Study	8
Kratom Use Among Pregnant and Lactating Individuals With Substance Use Disorder	8
Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia	8
Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation	8
Barriers and Facilitators to Accessing Opioid Agonist Therapy for Street-involved Adolescents and Young Adults in Vancouver	8
The Use of a Single Dose of Phenobarbital for Inpatient Management of Benzodiazepine Withdrawal: A Case Report	8
A Scoping Review of Youth Overdose Prevention Interventions	8
Complexities in Assessing Pregnancy-related Outcomes Among Patients Receiving Interdisciplinary Treatment for an Opioid Use Disorder	8
Simultaneous Management of Alcohol Use Disorder and Liver Disease: A Systematic Review and Meta-analysis	8
Reply to: “Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine”	8
Missed Opportunities: Substance Use Hotline Operator Uncertainty of State Buprenorphine Prescribing via Telemedicine	8
Direct Induction of Buprenorphine Extended-Release: A Case Report	8
Aripiprazole Is Not Effective for Abstinence or Decreased Use in Alcohol and Stimulant Use Disorders in Patients Without Psychiatric Comorbidities: A Systematic Review	8
Addiction Services for Veterans: Opportunities in Acute Care	8
Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice	8
N-acetylcysteine Efficacy on Cocaine Base Paste Use Disorder: A Randomized Double-blind Placebo-controlled Clinical Trial	8
Wound Care Capacity of the Addiction Workforce in the Setting of Xylazine	8
Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial	8
Response to "Two Clinical Insights on Methamphetamine Withdrawal at a Safety-net Hospital"	8
Artificial Intelligence and Stigma in Addiction Research: Insights From the HEALing Communities Study Coalition Meetings	7
“Just Be There”: Desired Partner Behaviors Among Pregnant People Living With Opioid Use Disorder, a Qualitative Study	7
Satisfaction With Opioid Agonist Treatment: The Compelling Need for Multidimensional, Patient-centered, Patient-reported Experience Measures	7
Response to: “Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial”	7
Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort Study	7
Stigmatizing Terminology for Outcomes and Processes (STOP) in Alcohol Research: A Meta-epidemiologic Assessment of Language Used in Clinical Trial Publications	7
Anhedonia and Substance Use Disorders by Type, Severity, and With Mental Health Disorders	7
Using Machine Learning to Predict Treatment Adherence in Patients on Medication for Opioid Use Disorder	7
Cannabis and Cannabinoids for Treating Pain: What Are the Data?	7
Predictors of the Rate of Illicit Fentanyl Metabolism in a Cohort of Pregnant Individuals	7
Heterogeneity in Prescription Opioid Misuse Motives by Age in Adolescents and Young Adults in the United States	7
Readmissions Among Patients With Surgically Managed Drug Use Associated-Infective Endocarditis Before and After the Implementation of an Addiction Consult Team: A Retrospective, Observational Analysis	7
Examining Racial/Ethnic and Income Disparities on Tobacco Product Use Among US Adults Within Wave 5 of the PATH Study	7
Validating the Waterpipe Addiction, Craving, and Anticipation Scale: An Exploratory Factor Analysis	7
Z-Drug Use and Benzodiazepine Use and Misuse Among LGB Populations: The Role of Psychological Distress	7
Prevalence of Kratom Use Disorder Among Kratom Consumers	7
Injection Drug Use and Healthcare Utilization in Patients Newly Diagnosed With HIV	7
Feasibility of a Brief Intervention to Decrease Harmful Alcohol Use Among Methadone Maintenance Treatment Clients in Shanghai: A Randomized Controlled Trial	7
Gabapentin Use During Pregnancy and Lactation With and Without Concurrent Opioid Exposure: Considerations and Future Directions	7
Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices	7
48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine	7
Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study	7
Concerns for Discharge of Persons Who Inject Drugs Home With Central Venous Catheters: A Letter to the Editor	7
Response to Martins et al.	6
Identifying Barriers to Buprenorphine Treatment for Patients with Opioid Use Disorder Among Anesthesiologists and Pain Practitioners: A Survey Study	6
The Impact of Frequency of Cannabis Use on Hypertensive Disorders During Pregnancy	6
Predictive Models to Assess Risk of Persistent Opioid Use, Opioid Use Disorder, and Overdose	6
The Concept of Treatment-Refractory Addiction: Implications for Addiction Treatment Systems and Research	6
Predictors of Treatment Completion in an Inpatient Substance Use Treatment Service in India	6
Development and Validation of a High-sensitivity Rapid Xylazine Dipstick for Clinical Urine Testing	6
Response to the Federation of State Physician Health Program's Commentary	6
Medication Initiation, Patient-directed Discharges, and Hospital Readmissions Before and After Implementing Guidelines for Opioid Withdrawal Management	6
Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment	6
Feasibility of an Inpatient Split-Dose Rapid Methadone Induction Protocol for Pregnant Individuals	6
Supervised Disulfiram Should Be Considered First-line Treatment for Alcohol Use Disorder	6
Challenges of Drug Testing in Addiction Treatment	6
Disparities in Buprenorphine Administration for Opioid Use Disorder in the Emergency Department	6
False-Positive Phosphatidylethanol Results Due to Blood Transfusion and Implications in the Process of Liver Transplantation Selection	6
Emergency Department Presentations Related to the Abuse of Illicit and Prescription Opioids Through a European Sentinel-centres–Based Registry	6
Health Care Service Presence, Social Vulnerability, and Opioid Overdose Rate Acceleration: A United States, County-level Analysis, 2020–2022	6
Patterns of Substance Use During Early Pregnancy and Associations With Behavioral Health Characteristics	6
Regular Kratom (Mitragyna speciosa Korth.) Use and Its Association With Endoplasmic Reticulum Stress Response	6
Parosmia Is Positively Associated With Problematic Drinking, as Is Phantosmia With Depressive Symptoms	6
Medications for Alcohol Use Disorder Among Birthing People With an Alcohol-related Diagnosis	6
Use of Practices to Reduce of Sudden Unexpected Infant Death Among Caregivers of Opioid Exposed Newborns	6
Disruption of Opioid Treatment Program Services Due to an Extreme Weather Event: An Example of Climate Change Effects on the Health of Persons Who Use Drugs	6
A Critical Appraisal on the Alleged Carcinogenic Potential of Sublingual Buprenorphine	6
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl	6
Effectiveness and Safety of Varenicline for Smoking Cessation: An Overview and Meta-analysis	6
Precipitated Opioid Withdrawal Treated With Ketamine in a Hospitalized Patient: A Case Report	5
Prescribing Psychostimulants for the Treatment of Stimulant Use Disorder: Navigating the Federal Legal Landscape	5
The American Society of Addiction Medicine Clinical Practice Guideline Development Methodology	5
Changes in Rates of Hospitalizations due to Cannabis Harms in Ontario, Canada Before the Legalization of Nonmedical Cannabis: Retrospective Population-level Study Between 2003 and 2017	5
Universal Postpartum Naloxone Provision: A Harm Reduction Quality Improvement Project	5
Opioid Use Disorder Among the Economically Disadvantaged in the Rural South	5
Outpatient Rapid Titration of Slow Release Oral Morphine for the Treatment of Opioid Use Disorder in a Canadian Setting: A Case Series	5
Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative	5
Circumstances Around Cigarette Use after Enforced Abstinence From Smoking in an American Prison	5

A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool	5
A Critique of Phenobarbital Tapers With Buprenorphine or Methadone Initiations	5
The First 100 Days: The Trump Administration and Changes to Addiction Policy	5
Participant Experiences of a Quit Smoking Attempt Through Either Nicotine Replacement Therapy (NRT) Methods or the Use of an E-cigarette	5
Explaining Racial-ethnic Disparities in the Receipt of Medication for Opioid Use Disorder during Pregnancy	5
Predictors of Risky Sexual Behaviors Among Female Adolescents and Young Adults Seeking Withdrawal Management Treatment: A Lifestyle-routine Activities Theory Approach	5
Naloxone Use During Pregnancy—Data From 26 US Jurisdictions, 2019–2020	5
Microdose Induction of Buprenorphine in a Patient Using Tianeptine	5
Does Labetalol Trigger False Positive Drug Testing Results?	5
The Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review	5
Exploring Preferences for Communication and Care Among Hospitalized Patients With Opioid Use Disorder: A Qualitative Descriptive Study	5
Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy	5
Safety and Efficacy of Rapid Methadone Titration for Opioid Use Disorder in an Inpatient Setting: A Retrospective Cohort Study	5
Expert Views on State Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder: A Qualitative Analysis of an Online Modified Delphi Process	5
Quetiapine: A Novel Additive to the Illicit Heroin Supply in Los Angeles	5
Privacy, Care-seeking, and Stigma: A Qualitative Investigation of Patient Perspectives on Sharing Substance Use Disorder Treatment Records	5
2024 ASAM Annual Conference Poster Abstracts	5
Risk of Cannabis Use Disorder in Chronic Pain: Longitudinal Links to Pain Outcomes	5
A Retrospective Cohort Study of Oral Antimicrobial Therapy Offers in Hospitalized People Who Inject Drugs Who Elect for Self-directed Discharge	5
Off-label Use of Lamotrigine and Naltrexone in the Treatment of Ketamine Use Disorder: A Case Report	4
Revisiting the X:BOT Naltrexone Clinical Trial Using a Comprehensive Survival Analysis	4
Effect of COVID-19 on the Long-term Cardiovascular Outcomes among Patients with Alcohol Use Disorder: A Retrospective Cohort Study Including 45,842 Patients	4
Homelessness and Treatment Outcomes Among Black Adults With Opioid Use Disorder: A Secondary Analysis of X:BOT	4
Medication for Opioid Use Disorder for Hospitalized Patients at Six New York City Public Hospitals With an Addiction Consult Service	4
Early Long-Acting Buprenorphine for Opioid Use Disorder in the Setting of Acute Pain	4
Financial Well-being and Impact on Alcohol and Mental Health Outcomes During the COVID-19 Pandemic	4
Age-related Psychometric Dimensionality Using the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition Opioid Use Disorder Diagnostic Criteria	4
Isolated Kratom Use Disorder Treated With Extended-Release Buprenorphine Taper	4
Self-reported Xylazine Experiences: A Mixed-methods Study of Reddit Subscribers	4
The Use of Extended-Release Buprenorphine in the Treatment of Adolescent Opioid Use Disorder: A Case Series	4
The Prognostic Role of DSM-5 Alcohol Use Disorder Severity and Age of Onset in Treatment Outcome Among Adults Aged 60+	4
Privacy and Digital Health: Causes for Concern and a Way Forward	4
Reductions in World Health Organization Risk Drinking Level Are Associated With Reductions in Alcohol Use Disorder Diagnosis and Criteria: Evidence From an Alcohol Pharmacotherapy Trial	4
Impact of Prenatal Cannabis Use Disorder on Perinatal Outcomes	4
Association Between Smoking Abstinence and Depression and Anxiety Symptoms After Hospital Discharge: The Helping HAND 4 Trial	4
Precipitated Withdrawal following Emergency Department-initiated Buprenorphine: A Retrospective Study	4
Trajectories of Opioid Misuse and Opioid Use Disorder Among Adults With Chronic Pain and HIV: An Observational Study	4
Differential Gateways, Facilitators, and Barriers to Substance Use Disorder Treatment for Pregnant Women and Mothers: A Scoping Systematic Review	4
Global, Regional, and National Burdens Attributable to Drug Use Across 204 Countries and Territories Between 1990 and 2021: The Global Burden of Disease Study 2021	4
Standard Versus Rapid Inpatient Methadone Titration for Pregnant Patients With Opioid Use Disorder: A Retrospective Cohort Study	4
Pandemics Interlaced: The Impact of the COVID-19 Pandemic on the Wellbeing of Sober Living Home Residents	4
Impact of Cocaine Use Disorder History on Receipt of Guideline-indicated Medications and Therapies Following ST-elevated Myocardial Infarction	4
A Quantitative Examination of Illness Models Among People With Opioid Use Disorder Receiving Methadone Treatment	4
The Associations of Kratom (Mitragynine), Opioids, Other Substances, and Sociodemographic Variables to Drug Intoxication–related Mortality	4
Factors Associated With the Presence of Co-occurring Pain and Substance Use Disorder Programs in Substance Use Treatment Facilities	4
Impact of X-Waiver Elimination on Post–Hospital Discharge Buprenorphine Prescribing: An Interrupted Time Series Analysis	4
Exploring Opioid Use Disorder Outcomes by Quantitative Urinalysis: Post Hoc Analysis of a Phase 3 Randomized Clinical Trial	4
An Integrated Care Model for Pregnant and Postpartum Individuals Receiving Medication for Opioid Use Disorder	4
Xylazine-associated Wounds: Clinical Experience From a Low-barrier Wound Care Clinic in Philadelphia	4
A Case of Phenibut Directed Detoxification Leading to Toxicity During the COVID-19 Pandemic	4
Description of Physician Champion Efforts to Expand Buprenorphine Treatment in Primary Care and Explore a Quality Implementation Measure of Success: Buprenorphine as a Percentage of All Opioids Prescr	4
Implementation of a Naloxone Best Practice Advisory Into an Electronic Health Record	4
Evaluation and Management of Buprenorphine Extended-Release Injection Thrombophlebitis: A Case Report	4
Integrating Ambulatory Addiction Consultation Service Into a Community Mental Health Center	4
An Attendance-based Contingency Management Pilot Program for Veterans Experiencing Homelessness With Stimulant-associated Cardiomyopathy in Primary Care	4
Low-dose Initiation of Buprenorphine in Hospitalized Patients Using Buccal Buprenorphine: A Case Series	4
National Provider Survey: Use of Naltrexone for Pregnant Individuals with Substance Use Disorders	4
Response to Avoiding NICU Transfer for Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS): A Quality Improvement Initiative to Manage NOWS on the Mother-baby Unit	4
Facilitating Integrated Perinatal Care for Families Affected by Substance Use	4
Dutasteride as a Treatment to Support Reduced Drinking: A Randomized Placebo-Controlled Trial	4
An Open-label Pilot Study of NicoBloc as a Novel Smoking Cessation Intervention	4
A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone	4
Perspectives of Patients Receiving Telemedicine Services for Opioid Use Disorder Treatment: A Qualitative Analysis of User Experiences	4
Racial Disparities in Urine Toxicology Screening Among Pregnant People Admitted to Labor and Delivery	4
Community Pharmacists’ Knowledge and Perceptions of Buprenorphine for Patients with Opioid Use Disorder	4
Expanding Medical Education to Include Substance Use Disorders During Pregnancy and Postpartum: Preliminary Effectiveness of a Pilot Curriculum for Medical Students	4
Xylazine Positivity in Opioid-positive Drug Screens on an Inpatient Labor Unit	4
Effectiveness of and Access to Medications for Opioid Use Disorder for Adolescents and Young Adults: A Scoping Review	4
Cannabis Use Behaviors and Desired Interventions Among Postpartum Individuals With Frequent Cannabis Use in Early Pregnancy: A Qualitative Study	3
Geographic Trends in Nonfatal Overdose Involving or Exposed to Opioids and Xylazine Across U.S. Emergency Departments	3
Interest in Transcranial Magnetic Stimulation Therapy for Treatment of Depression and Substance Use Disorder Among Peripartum Individuals	3
Maternal Perception of Infant Sleep and Bonding in Opioid Use Disorder	3
Naltrexone in the Treatment of Ketamine Use Disorders: A Case Report and Literature Review	3
Thirty-day Treatment Continuation After Audio-only Buprenorphine Telehealth Initiation	3
Hospital-initiated Extended-release Injectable Buprenorphine Using a Novel Reallocation Initiative From an Outpatient Addiction Medicine Clinic	3
Sex Differences in Illicitly Manufactured Fentanyl Use: Prevalence and Sociodemographic, Health, and Environmental Correlates	3
Providing Low-barrier Addiction Treatment Via a Telemedicine Consultation Service During the COVID-19 Pandemic in Los Angeles, County: An Assessment 1 Year Later	3
Trends and Associations in Patient Ratings Using the American Society of Addiction Medicine Criteria, 2013–2022	3
Disulfiram Should Remain Second-line Treatment for Most Patients With Alcohol Use Disorder	3
Physician-approved protocols increase naloxone dispensing rates	3
Trends in Characteristics of Prescription Opioid-related Poisonings among Older Adults in the United States, 2015–2021	3
Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes	3
Real-World Evidence for Impact of Opioid Agonist Therapy on Nonfatal Overdose in Patients With Opioid Use Disorder During the COVID-19 Pandemic: Erratum	3
2023 Poster Abstracts	3
Association of Counseling and Psychotherapy on Retention in Medication for Addiction Treatment Within a Large Medicaid Population	3
Pregnancy and Pregnancy Outcomes in a National Population Cohort of Patients Treated for Substance Use Disorders	3
Injection of Methamphetamine Has Increased in Boston, Massachusetts: 5 Waves of Centers for Disease Control and Prevention State Surveillance Data	3
The Postpartum Period: An Opportunity for Alcohol Screening and Counseling to Reduce Adverse Health Impacts	3
Facilitation and Preferred Models for Delivering Substance Use Disorder Treatment in HIV Clinics: Results From a Multisite Randomized Trial	3
Take-home Naloxone at Opioid Treatment Programs: A Lifesaver	3
Machine Learning–Driven Analysis of Individualized Treatment Effects Comparing Buprenorphine and Naltrexone in Opioid Use Disorder Relapse Prevention	3
Impact of Nicotine Replacement Therapy Sampling on Cessation-Related Processes	3
Rejection of Patients With Opioid Use Disorder Referred for Post-acute Medical Care Before and After an Anti-discrimination Settlement in Massachusetts: Erratum	3
Temporal Trends in Methamphetamine Use in Patients Admitted to the Hospital: A Retrospective Cohort Study	3
Brief Report on Outpatient Treatment of Adolescent Opioid Use Disorder	3